Semaglutide 30mg
Semaglutide is a synthetic 31-amino-acid analogue of glucagon-like peptide-1 (GLP-1) with substitutions and a fatty-acid moiety that confer extended albumin-binding stability in research preparations. It is a reference long-acting GLP-1 receptor agonist in preclinical metabolic-research literature. Lyophilized under inert atmosphere. Reconstitute with sterile bacteriostatic water; store reconstituted samples refrigerated. For laboratory and research use only. Not for human or veterinary use.
Product Details
Semaglutide 30mg is synthesized using advanced solid-phase peptide synthesis (SPPS) technology and purified to ≥99% via preparative HPLC. Each vial contains lyophilized peptide verified by electrospray ionization mass spectrometry (ESI-MS) for exact molecular mass confirmation. The lyophilization process is performed under inert nitrogen atmosphere to prevent oxidation and ensure maximum shelf stability. Supplied as a white to off-white lyophilized powder. Reconstitute with bacteriostatic water (0.9% benzyl alcohol) for optimal peptide preservation. Store reconstituted solutions at 2-8°C and use within 30 days.
Research Focus & Mechanism Overview
Semaglutide 30mg has been extensively characterized in preclinical research literature for its receptor binding affinity and downstream signaling activity. Published studies indicate dose-dependent activation of target receptor pathways with high selectivity. The compound demonstrates favorable pharmacokinetic properties in standard in-vitro assay systems, including rapid binding kinetics and sustained receptor engagement. Researchers should note the compound's stability profile under various buffer conditions when designing experimental protocols. Recommended for use in comparative pharmacological profiling, receptor binding assays, dose-response characterization, and mechanistic pathway studies.
Quality & Purity Standards
Every batch is tested in-house and verified by independent third-party laboratories. Purity ≥99% by HPLC. Identity confirmed via LC-MS. Endotoxin levels <0.1 EU/mg. Heavy metals below ICH Q3D limits. Peptide content ≥80% by weight (net peptide). Certificate of Analysis (COA) available for download on this page.
Compliance Notice
This product is intended solely for in-vitro research and laboratory use. It is not a drug, food, supplement, or cosmetic. Not approved for human or veterinary use. Purchasers assume full responsibility for compliance with applicable local, state, and federal regulations. By purchasing, you confirm that you are a qualified researcher or institution and that this product will not be used for any unauthorized purpose.
Also Considered.
FREQUENTLY ASKED
QUESTIONS
How should I reconstitute Semaglutide 30mg?
Slowly inject bacteriostatic water along the inside wall of the vial to avoid foaming. Do not shake — gently swirl until the powder is fully dissolved. Use sterile technique throughout. Store reconstituted solution refrigerated at 2-8°C and use within 30 days.
What purity is guaranteed for Semaglutide 30mg?
Every batch is tested in-house via HPLC and independently verified by third-party LC-MS analysis. We guarantee a minimum purity of ≥99%. Certificates of Analysis (COA) are available for download on each product page.
How should I store Semaglutide 30mg?
Store lyophilized (unreconstituted) vials at -20°C for long-term storage or 2-8°C for short-term. Protect from light and moisture. Reconstituted peptide should be kept refrigerated at 2-8°C and used within 30 days. Avoid repeated freeze-thaw cycles.
Is this product approved for human use?
No. All Sparta Labs products are strictly intended for in-vitro laboratory research only. They are not drugs, supplements, or food products. Not approved by the FDA or any regulatory body for human or veterinary use.